XML 70 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
EQUITY (Details Narrative) - USD ($)
12 Months Ended
May 12, 2023
Dec. 31, 2023
Dec. 31, 2022
May 16, 2023
Subsidiary, Sale of Stock [Line Items]        
Issuance of shares   7,731,618    
Warrants to purchase common stock   53,396,008    
Exercise of prefunded warrants   307,260    
Preferred stock stated value [1]    
Capital stock shares authorized   155,000,000    
Capital stock par value   $ 0.0001    
Common stock shares authorized   150,000,000 150,000,000  
Restricted Stock [Member]        
Subsidiary, Sale of Stock [Line Items]        
Weighted average of the remaining contractual life of vested and exercisable options   7 years 6 months 14 days    
Aggregate intrinsic value of exercisable options   $ 10,983    
Restricted Stock [Member] | Consultants [Member]        
Subsidiary, Sale of Stock [Line Items]        
Stock option exercise price   $ 1.95 $ 2.42  
Share-Based Payment Arrangement, Option [Member] | Employees and Directors [Member]        
Subsidiary, Sale of Stock [Line Items]        
Stock option exercise price   1.65 2.33  
Share-Based Payment Arrangement, Option [Member] | Consultants [Member]        
Subsidiary, Sale of Stock [Line Items]        
Stock option exercise price   1.50 $ 2.57  
Restricted Stock Units (RSUs) [Member] | Consultants [Member]        
Subsidiary, Sale of Stock [Line Items]        
Stock option exercise price   $ 1.76    
Employee And Non Employee Stock Option [Member]        
Subsidiary, Sale of Stock [Line Items]        
Unvested stock-based compensation   $ 7,180,000    
Unvested stock-based compensation weighted-average period for recognition   11 months 19 days    
Series C Preferred Stock [Member]        
Subsidiary, Sale of Stock [Line Items]        
Preferred stock conversion price $ 1.3827      
Preferred stock convertible shares issuable 5,668 7,952 2,284  
Preferred stock outstanding   1,718 1,718 1,718
Preferred stock stated value   $ 10,997 $ 10,997  
Preferred stock shares authorized   1,172,000 1,172,000  
Pre-Funded Warrants [Member]        
Subsidiary, Sale of Stock [Line Items]        
Warrant exercise price $ 0.0001      
Warrants outstanding   15,254,623    
Warrant [Member]        
Subsidiary, Sale of Stock [Line Items]        
Warrants to purchase common stock   307,271    
Warrant exercise price $ 1.3827      
Preferred Stock Blank Check [Member]        
Subsidiary, Sale of Stock [Line Items]        
Preferred stock shares authorized   5,000,000    
Private Placement [Member]        
Subsidiary, Sale of Stock [Line Items]        
Issuance of shares 10,266,270      
Private placement $ 42,200,000      
Fees payable and other offering expenses 4,600,000      
Gross proceeds from warrant exercises $ 71,400,000      
Private Placement [Member] | Pre-Funded Warrants [Member]        
Subsidiary, Sale of Stock [Line Items]        
Warrants to purchase common stock 15,561,894      
Offering price per share $ 1.6326      
Private Placement [Member] | Warrant [Member]        
Subsidiary, Sale of Stock [Line Items]        
Warrants to purchase common stock 51,656,328      
Offering price per share $ 1.6327      
Private Placement [Member] | Series H Warrants [Member]        
Subsidiary, Sale of Stock [Line Items]        
Warrants to purchase common stock 12,914,086      
Private Placement [Member] | Series I Warrants [Member]        
Subsidiary, Sale of Stock [Line Items]        
Warrants to purchase common stock 12,914,078      
Private Placement [Member] | Series J Warrants [Member]        
Subsidiary, Sale of Stock [Line Items]        
Warrants to purchase common stock 12,914,086      
Private Placement [Member] | Series K Warrants [Member]        
Subsidiary, Sale of Stock [Line Items]        
Warrants to purchase common stock 12,914,078      
At The Market Offering [Member] | Warrant [Member]        
Subsidiary, Sale of Stock [Line Items]        
Warrants to purchase common stock   53,396,008    
[1] Represents an amount less than $1